Resylate Tablet
Etamsylate (Ethamsylate)
500mg
Alive Pharmaceutical. Pvt. Ltd.
| Pack size | 1 |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price |
Indications
Resylate Tablet is used for:
Menorrhagia, Control of haemorrhage after surgery
Adult Dose
Oral
Menorrhagia
Adult: 500 mg 4 times daily during menstruation.
Control of haemorrhage after surgery
Adult: 250-500 mg every 4-6 hr as needed. May also be given via IV/IM inj.
Child Dose
Parenteral
Treatment and prophylaxis of periventricular haemorrhage in low birth-weight neonates
Child: Low birth-weight neonate: 12.5 mg/kg IM/IV Inj every 4-6 hr.
Renal Dose
Administration
May be taken with or without food. May be taken w/ meals to minimise GI upset.
Contra Indications
Hypersensitivity. Porphyria. Pregnancy and lactation.
Precautions
Pregnancy & breastfeeding.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Etamsylate (Ethamsylate) :
Headache, skin rash, nausea. IV: Transient hypotension.
Mechanism of Action
Ethamsylate stops haemorrhage from small blood vessels by stabilising the capillary wall and correcting abnormal platelet adhesion.
Note
Resylate 500mg Tablet manufactured by Alive Pharmaceutical. Pvt. Ltd.. Its generic name is Etamsylate (Ethamsylate). Resylate is availble in Nepal.
Farmaco Nepal drug index information on Resylate Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.